![Daniel Baker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Baker
Direktor/Vorstandsmitglied bei
SHATTUCK LABS, INC.
Vermögen: - $ am 31.05.2026
Profil
Daniel G.
Baker is currently an Independent Director at Shattuck Labs, Inc. and Artiva Biotherapeutics, Inc., both starting in 2025.
Dr. Baker is also the Chief Development Officer at Cue Biopharma, Inc. since 2024.
Formerly, Dr. Baker was Chief Executive Officer & Director at Kira Biotech Pty Ltd. Dr. Baker was an Independent Non-Executive Director at Lakefront Biotherapeutics from 2022 to 2024.
From 2000 to 2019, Dr. Baker was Vice President-Immunology R&D at Johnson & Johnson.
Dr. Baker earned a doctorate from the University of Pennsylvania and completed undergraduate studies at Gettysburg College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Daniel Baker
| Unternehmen | Position | Beginn |
|---|---|---|
| CUE BIOPHARMA, INC. | Corporate Officer/Principal | 25.11.2024 |
| ARTIVA BIOTHERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 28.01.2025 |
| SHATTUCK LABS, INC. | Direktor/Vorstandsmitglied | 25.08.2025 |
Ehemalige bekannte Positionen von Daniel Baker
| Unternehmen | Position | Ende |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Direktor/Vorstandsmitglied | 06.10.2024 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01.01.2019 |
Kira Biotech Pty Ltd.
 Kira Biotech Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders | Vorstandsvorsitzender | - |
Ausbildung von Daniel Baker
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
87
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gettysburg College
 Gettysburg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Shattuck Labs, Inc.
 Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
Kira Biotech Pty Ltd.
Kira Biotech Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders | Health Technology |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
